Genentech chemistry leadership shifts | January 1, 2018 Issue - Vol. 96 Issue 1 | Chemical & Engineering News
Volume 96 Issue 1 | p. 13 | Concentrates
Issue Date: January 1, 2018

Genentech chemistry leadership shifts

Department: Business
Keywords: People, Genentech, medicinal chemistry
[+]Enlarge
Young
Credit: Genentech
A photo of Genentech's Wendy Young.
 
Young
Credit: Genentech

Medicinal chemist Wendy Young has been promoted to senior vice president for small-molecule drug discovery at Genentech. Young previously led a team of roughly 100 medicinal, computational, and analytical chemists; she will now run the 350-scientist small-molecule research engine for Genentech, a subsidiary of Roche. Young is taking over the reins from medicinal chemist Bruce Roth, who is retiring. Roth, known for being the first to synthesize atorvastatin—better known as Pfizer’s multi-billion-dollar cholesterol-lowering drug Lipitor, joined Genentech in 2007, after Pfizer laid off thousands of scientists at its Ann Arbor, Mich., site.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment